Oleh Hornykiewicz

Vienna, 1090, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implications.

Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implications.

Journal: The European journal of neuroscience

Published: May 20, 2017

Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.

Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.

Journal: Brain : a journal of neurology

Published: March 27, 2017

L-DOPA.

L-DOPA.

Journal: Journal of Parkinson's disease

Published: March 12, 2017

Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implications.

Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implications.

Journal: The European journal of neuroscience

Published: June 20, 2016

A marked contrast between serotonergic and dopaminergic changes in dopa-responsive dystonia.

A marked contrast between serotonergic and dopaminergic changes in dopa-responsive dystonia.

Journal: Neurology

Published: March 06, 2016

Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.

Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.

Journal: Neurobiology of disease

Published: April 08, 2015

50 years of levodopa.

50 years of levodopa.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 09, 2015

The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.

The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.

Journal: European journal of pharmacology

Published: January 08, 2015

Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum.

Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience

Published: June 13, 2014

Reduced noradrenaline, but not dopamine and serotonin in motor thalamus of the MPTP primate: relation to severity of parkinsonism.

Reduced noradrenaline, but not dopamine and serotonin in motor thalamus of the MPTP primate: relation to severity of parkinsonism.

Journal: Journal of neurochemistry

Published: November 27, 2012

Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms.

Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: April 06, 2012

The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study.

The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study.

Journal: Neurobiology of disease

Published: February 11, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026